Mexican tomato exporters are conducting unfair trade practices and dumping tomatoes into the U.S. market, despite the 2019 Tomato Suspension Agreement. This is forcing American tomato farmers out of business and destroying the domestic tomato industry. U.S....
U.S. Senator Marco Rubio’s (R-FL) office will host in-person and virtual Mobile Office Hours next week to assist constituents with federal casework issues in their respective local communities. These office hours offer constituents who do not live close to one of...
El senador estadounidense Marco Rubio (R-FL) habló con Nio Encendio de Maxima 92.5 de Tampa Bay, sobre cómo la inflación ha impactado a las familias, sobre las olas de migración ilegal, sobre el juicio político de Biden vs. el de Trump, sobre el canje de prisioneros...
This year alone, U.S. Customs and Border Protection (CBP) has encountered an estimated 40,000 Chinese nationals along the U.S. northern and southern border. The Biden Administration has left the border wide open, allowing potential spies from the Chinese Communist...
Gotion, Inc., a Chinese company and U.S. subsidiary of Guoxuan High-Tech, announced a lithium battery plant in Illinois that is expected to open next year. This CCP-tied battery company is expected to benefit from green-energy tax breaks under the Democrats’ Inflation...
U.S. Senator Marco Rubio (R-FL) joined National Public Radio’s All Things Considered to discuss his plan to expand the child tax credit for working families. See below for the full transcript and listen to the edited interview here. On the connection between the child...
Congress must pass the Give Kids a Chance Act without delay
U.S. Senator Marco Rubio (R-FL)
September 8, 2022
The Hill
…In 2017, Congress passed the RACE for Children Act, which Sen. Bennet [D-CO] and I wrote to streamline the approval of pediatric cancer drugs and require that single-drug therapy trials be applied to children as well as adults. According to the chair of the Children’s Oncology Group, it was a “huge…game-changer.” Our new bill [the Give Kids a Chance Act] builds off of that law’s success to help more children….
In combination therapy trials, the U.S. Food and Drug Administration (FDA) approves patients’ advance access to innovative combinations of molecularly-targeted oncology drugs or biologics. It’s one of the primary ways in which doctors develop new, life-saving cancer treatments. But because of outdated red tape,…children suffering from pediatric cancers are stuck with less effective, single-drug treatments.
There isn’t a good reason to deny children battling a horrible disease the care they need. Fortunately, we…can make even more progress by…expanding the RACE for Children Act’s pediatric study requirement to combination therapy trials. That is what our Give Kids a Chance Act would do.
The Pediatric Oncology Section Head of Children’s Hospital Colorado confirms that our bill would “increase access to combinations of target cancer drugs” and bring new hope to “children and families who most need new treatment options.” Nor is that the only testimonial it has received. Dozens of hospitals, advocacy groups, and pediatric cancer research organizations have endorsed the Give Kids a Chance Act….
The House of Representatives has already incorporated a companion piece of legislation…into its version of the FDA user fee reauthorization bill. Now it’s time for the House and Senate to incorporate the Give Kids a Chance Act into the final reauthorization bill, before those fees expire at the end of September, and pass it as soon as possible….
Read the rest here.